Physician profile
John Mark Bennett
NPI 1033189717
$1,151.04
in general payments reported to CMS, 2019-2025
17 companies · $27.20 in 2025
The $27.20 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $318 · 2022: $208 · 2024: $42.43 · 2025: $27.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $293.30 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $165.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $157.02 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $69.69 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $57.23 | 2019-2020 | |
| Lilly USA, LLC | $53.76 | 2019-2022 | |
| Inari Medical, INC. | $42.43 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $40.42 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.34 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $31.77 | 2019-2020 | |
| Astellas Pharma US INC | $30.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.57 | 2019-2020 | |
| Amgen INC. | $27.20 | 2025 | Krystexxa |
| Genentech USA, INC. | $16.12 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.35 | 2019 | |
| Pfizer INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.